A Study to Assess the Role of Technology for the Detection of Hearing Loss
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 19-003363
Sponsor Protocol Number: 19-003363
About this study
The purpose of this study is to evaluate available tablet-based technology that can be easily used to screen and monitor patients for the detection of hearing loss in a quiet, clinic setting.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Individuals aged 18-80 years old.
- Scheduled to receive a hearing test as part of Executive Health Program.
- Able to give informed consent.
- English-speaking.
Exclusion Criteria:
- Patients < 18 years or > 80 years old.
- Non-English speaking (instructions on tablet in English-only).
- Specialized populations (adult developmentally delay, cognitive decline, etc.).
- Vulnerable populations (e.g., prisoners, severe mentally illness etc.).
- Additional handicap that would limit the patient from being able to follow study instructions.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Gayla Poling, Ph.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available